The Effect of Bay Leaf Extract (Syzygium polyanthum) on Reducing Overexpression of Matrix Metalloproteinases-13 in Acute Coronary Syndrome
DOI:
https://doi.org/10.3889/oamjms.2020.4940Keywords:
matrix metalloproteinase, immunohistochemistry, acute coronary syndrome, bay leaf, plant extractAbstract
AIM: The objective of the study was to determine the inhibitory effect of bay leaf (Syzygium polyanthum) on matrix metalloproteinases (MMPs) (MMP-9 and MMP-13) inhibitory effect in surgery-induced acute coronary syndrome (ACS) rat model.
METHODS: This study was experimental animal study. Thirty-two surgery-induced ACS Wistar rats (Rattus norvegicus) divided into 16 bay leaf extract (treatment) group and 16 control groups were sacrificed on days 1, 3, 7, and 14 after induction. Expressions of MMP-9 and MMP-13 were determined by immunohistochemistry and its scoring was assessed by two-blinded experienced pathologists. The immunohistochemical scoring of MMP-9 and MMP-13 between groups was analyzed using independent sample t-test and within groups by using one-way ANOVA test.
RESULTS: The expression of MMP-13 in treatment group was decreased compared to control group on days 7 and 14 (p = 0.001 and p = 0.015, respectively). Compared to day 1, the reduction expression of MMP-13 was significant in both control group and treatment group (p = 0.009 and p = 0.003, respectively). There were no significant changes in expression of MMP-9 between groups, and within control group and treatment group.
CONCLUSION: Bay leaf can reduce the overexpression of MMP-13 in surgery-induced ACS rat model. Bay leaf extract can be considered to be given as an adjuvant to prevent cardiovascular adverse event and adverse cardiac remodeling post-ACS.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. https://doi. org/10.21037/atm.2016.06.33 PMid:27500157
Setianto BY, Mubarika S, Irawan B, Astuti I. Association between high serum matrix metalloproteinase-9 and MMP-9 (-1562C>T) polymorphism in patients with ST-elevation acute myocardial infarction. Cardiol Res. 2012;3(5):222-9. https://doi. org/10.4021/cr210w PMid:28348691
Akasaka T, Kubo T, Mizukoshi M, Tanaka A, Kitabata H, Tanimoto T, et al. Pathophysiology of acute coronary syndrome assessed by optical coherence tomography. J Cardiol. 2010;56(1):8-14. https://doi.org/10.1016/j.jjcc.2010.05.005 PMid:20554431
Newby AC. Metalloproteinase production from macrophages-a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction. Exp Physiol. 2016;101(11):1327-37. https://doi.org/10.1113/ep085567 PMid:26969796
Hamed GM, Fattah MF. Clinical relevance of matrix metalloproteinase 9 in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2015;21(8):705-11. https://doi. org/10.1177/1076029614567309 PMid:25616488
Spinale FG, Villarreal F. Targeting matrix metalloproteinases in heart disease: Lessons from endogenous inhibitors. Biochem Pharmacol. 2014;90(1):7-15. https://doi.org/10.1016/j. bcp.2014.04.011 PMid:24780447
Montague SJ, Gardiner EE. Matrix metalloproteinase-13 unlucky for the forming thrombus. Res Pract Thromb Haemost. 2018;2(3):525-8. https://doi.org/10.1002/rth2.12105 PMid:30046757
Van Doren SR. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 2015;44-46:224-31. https://doi. org/10.1016/j.matbio.2015.01.005 PMid:25599938
Lahdentausta L, Leskelä J, Winkelmann A, Tervahartiala T, Sorsa T, Pesonen E, et al. Serum MMP-9 diagnostics, prognostics, and activation in acute coronary syndrome and its recurrence. J Cardiovasc Transl Res. 2018;11(3):210-20. https://doi.org/10.1007/s12265-018-9789-x PMid:29349668
Kobayashi N, Takano M, Hata N, Kume N, Tsurumi M, Shirakabe A, et al. Matrix metalloproteinase-9 as a marker for plaque rupture and a predictor of adverse clinical outcome in patients with acute coronary syndrome: An optical coherence tomography study. Cardiology. 2016;135(1):56-65. https://doi. org/10.1159/000445994 PMid:27271099
Hadipurnomo S, Setianto BY, Dinarti LK. Correlation of serum levels of matrix metalloproteinase-9 to acute heart failure event as a complication af acute coronary syndrome. Acta Cardiol Indones. 2015;1(1):8-12.
Novira PP, Febrina E. Review of pharmacological activity of bay leaf extract (Syzygium polyanthum (Wight.) Walp). Farmaka. 2018;16:288-97.
Hasan R, Lindarto D, Siregar GA, Mukhtar Z. The effect of bay leaf extract Syzygium polyanthum (Wight) Walp. On C-reactive protein (CRP) and myeloperoxidase (MPO) level in the heart of rat model of myocardial infarction. Med Glas (Zenica). 2020;17(1):1-5. PMid:31601063
A’Yun NQ, Sari NP, Putra RS. The effect of Salam leaf (Syzygium polyanthum Wight) decoction to reduce uric acid levels in humans’ blood: An attempt to globalize traditional medicine. In: Proceeding Book 7th Asian Academic Society International Conference; 2019. p. 253-6.
Raychaudhuri S, Ghosh S, Roy A, Swarnakar S. Protective role of black tea flavonoids against ethanol-induced gastropathy via matrix metalloproteinase pathway. Indian J Clin Biochem. 2019;34(4):379-94. https://doi.org/10.1007/s12291-018-0762-x PMid:31686725
Haleagrahara N, Hodgson K, Miranda-Hernandez S, Hughes S, Kulur AB, Ketheesan N. Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis. Inflammopharmacology. 2018;26(5):1219-32. https://doi.org/10.1007/s10787-018-0464-2 PMid:29616452
Anajafi T, Sedigh A, Mallik S. Naturally occurring matrix metalloproteinase inhibitors: A group of promising cardioprotective agents: Promises and hopes. In: Cardioprotective Natural Products: Promises and Hopes. Singapore: World Scientific; 2017. p. 9-46. https://doi.org/10.1142/9789813231160_0002
Syahreza A, Syafril S, Lindarto D. Comparison of sambiloto (Andrographis paniculata (Burm. f.) Nees) and Salam (Syzygium polyanthum (wight) walp) extract mixture with simvastatin on ferritin concentration in dyslipidemic patients. J Med Plants Stud. 2018;6(6):4-7.
Hartanti L, Yonas SM, Mustamu JJ, Wijaya S, Setiawan HK, Soegianto L. Influence of extraction methods of bay leaves (Syzygium polyanthum) on antioxidant and HMG-CoA reductase inhibitory activity. Heliyon. 2019;5(4):e01485. https:// doi.org/10.1016/j.heliyon.2019.e01485 PMid:31008409
Wu Y, Yin X, Wijaya C, Huang MH, McConnell BK. Acute myocardial infarction in rats. J Vis Exp. 2011;48:2464. PMid:21372786
Wilson EM, Moainie SL, Baskin JM, Lowry AS, Deschamps AM, Mukherjee R, et al. Region-and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation. 2003;107(22):2857-63. https://doi.org/10.1161/01. cir.0000068375.40887.fa PMid:12771000
Huang W, Sala-Newby GB, Susana A, Johnson JL, Newby AC. Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κB. PLoS One. 2012;7(8):e42507. https:// doi.org/10.1371/journal.pone.0042507 PMid:22880008
Howes J, Pugh N, Hamaia SW, Jung SM, Knauper V, Malcor J, et al. MMP-13 binds to platelet receptors αIIbβ3 and GPVI and impairs aggregation and thrombus formation. Res Pract Thromb Haemost. 2018;2(2):370-9. https://doi.org/10.1002/rth2.12088 PMid:30046741
Amar S, Smith L, Fields GB. Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta Mol Cell Res. 2017;1864(11):1940-51. https://doi.org/10.1016/j. bbamcr.2017.04.015 PMid:28456643
Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999;99(19):2503-9. https:// doi.org/10.1161/01.cir.99.19.2503 PMid:10330380
Quillard T, Tesmenitsky Y, Croce K, Travers R, Shvartz E, Koskinas KC, et al. Selective inhibition of matrix metalloproteinase 13 (MMP-13) increases collagen content of established mouse atheromata. Arterioscler Thromb Vasc Biol. 2011;31(11):2464- 72. https://doi.org/10.1161/atvbaha.111.231563 PMid:21903941
Downloads
Published
How to Cite
License
Copyright (c) 2020 Refli Hasan, Gontar Alamsyah Siregar, Dharma Lindarto (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0